Skedgel C - Search Results

1

Adherence to guidelines and the screening tool of older persons' potentially inappropriate prescriptions criteria for colchicine dosing for gout treatment in beneficiaries of the Nova Scotia Seniors' Pharmacare Program.

Black E, Sketris I, Skedgel C, MacLean E, Hanly JG. Black E, et al. Among authors: skedgel c. Clin Ther. 2015 Oct 1;37(10):2339-46. doi: 10.1016/j.clinthera.2015.08.016. Epub 2015 Sep 29. Clin Ther. 2015. PMID: 26391146

2

Hospital-based psychiatric service utilization and morbidity in multiple sclerosis.

FisK JD, Morehouse SA, Brown MG, Skedgel C, Murray TJ. FisK JD, et al. Among authors: skedgel c. Can J Neurol Sci. 1998 Aug;25(3):230-5. doi: 10.1017/s0317167100034065. Can J Neurol Sci. 1998. PMID: 9706725

3

Cost-effectiveness of interferon beta-1b in slowing multiple sclerosis disability progression. First estimates.

Brown MG, Murray TJ, Sketris IS, Fisk JD, LeBlanc JC, Schwartz CE, Skedgel C. Brown MG, et al. Among authors: skedgel c. Int J Technol Assess Health Care. 2000 Summer;16(3):751-67. doi: 10.1017/s026646230010203x. Int J Technol Assess Health Care. 2000. PMID: 11028131

4

Topical corticosteroid prescribing patterns following changes in drug benefit status.

Campbell CA, Cooke CA, Weerasinghe SD, Sketris IS, McLean-Veysey PR, Skedgel CD. Campbell CA, et al. Ann Pharmacother. 2003 Jun;37(6):787-93. doi: 10.1345/aph.1C196. Ann Pharmacother. 2003. PMID: 12773062

5

The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors' Pharmacare beneficiaries.

Sketris IS, Kephart GC, Frail DM, Skedgel C, Allen MJ. Sketris IS, et al. Among authors: skedgel c. Pharmacotherapy. 2004 Jun;24(6):784-91. doi: 10.1592/phco.24.8.784.36073. Pharmacotherapy. 2004. PMID: 15222669

6

An incremental cost analysis of telehealth in Nova Scotia from a societal perspective.

Persaud DD, Jreige S, Skedgel C, Finley J, Sargeant J, Hanlon N. Persaud DD, et al. Among authors: skedgel c. J Telemed Telecare. 2005;11(2):77-84. doi: 10.1258/1357633053499877. J Telemed Telecare. 2005. PMID: 15829051

7

Use of physician profiles to influence prescribing of topical corticosteroids.

Sketris IS, Kephart G, Cooke CA, Skedgel CD, McLean-Veysey PR; Drug Evaluation Alliance of Nova Scotia. Sketris IS, et al. Can J Clin Pharmacol. 2005 Summer;12(2):e186-97. Epub 2005 Jun 17. Can J Clin Pharmacol. 2005. PMID: 15998957

8

Effect of copayments on drug use in the presence of annual payment limits.

Kephart G, Skedgel C, Sketris I, Grootendorst P, Hoar J. Kephart G, et al. Among authors: skedgel c. Am J Manag Care. 2007 Jun;13(6 Pt 2):328-34. Am J Manag Care. 2007. PMID: 17567233

9

How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?

Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS. Brown MG, et al. Among authors: skedgel c. Neurology. 2007 Oct 9;69(15):1498-507. doi: 10.1212/01.wnl.0000271884.11129.f3. Epub 2007 Aug 15. Neurology. 2007. PMID: 17699802

10

Gout in the elderly--a population health study.

Hanly JG, Skedgel C, Sketris I, Cooke C, Linehan T, Thompson K, van Zanten SV. Hanly JG, et al. Among authors: skedgel c. J Rheumatol. 2009 Apr;36(4):822-30. doi: 10.3899/jrheum.080768. Epub 2009 Mar 13. J Rheumatol. 2009. PMID: 19286852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results